A prospective double-blind trial by Boonen et al[35] reported that administering a complex of IGF-1 coupled with IGFBP-3 reduced femoral bone loss and improved functional outcomes in elderly patients with a hip fracture. The gene discussed is IGFBP3; the disease is hip fracture.